Dr. James E Davis, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3705 Midway Dr, Baker City, OR 97814 Phone: 541-523-6428 Fax: 541-523-4713 |
News Archive
Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that Palmetto GBA and TrailBlazer Health Enterprises, LLC - two large regional Medicare carriers serving over 10.2 million beneficiaries in California, Nevada, Hawaii, Texas, Oklahoma, Colorado, New Mexico and Virginia - have agreed to cover the Renessa(R) treatment for female SUI (stress urinary incontinence) in appropriately selected patients with documented medical necessity.
According to the Centers for Disease Control (CDC), endometriosis, a gynecological disorder in which cells from the uterus lining grow in other areas of the body, is the number one reason for a hysterectomy in women ages 18-35. Current treatment options for endometriosis are severely limited by side effects of existing medications and surgical options have more risks. A nationwide clinical trial is testing an investigational drug as a potential new option for patients with moderate to severe pain from this disease.
A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer - the second-leading cause of cancer-related deaths in the U.S.
The Communications Workers of America commends House Speaker Nancy Pelosi and the House of Representatives on passage of its health care plan.
Cancer Treatment Centers of America at Western Regional Medical Center has dosed its first three patients as part of the launch of a Phase I clinical trial using a novel antibody to treat patients with advanced solid tumors.
› Verified 2 days ago